Cite
Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.
MLA
Ashford, Anne, et al. “Identification of DYRK1B as a Substrate of ERK1/2 and Characterisation of the Kinase Activity of DYRK1B Mutants from Cancer and Metabolic Syndrome.” Cellular & Molecular Life Sciences, vol. 73, no. 4, Feb. 2016, pp. 883–900. EBSCOhost, https://doi.org/10.1007/s00018-015-2032-x.
APA
Ashford, A., Dunkley, T., Cockerill, M., Rowlinson, R., Baak, L., Gallo, R., Balmanno, K., Goodwin, L., Ward, R., Lochhead, P., Guichard, S., Hudson, K., & Cook, S. (2016). Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome. Cellular & Molecular Life Sciences, 73(4), 883–900. https://doi.org/10.1007/s00018-015-2032-x
Chicago
Ashford, Anne, Tom Dunkley, Mark Cockerill, Rachel Rowlinson, Lisa Baak, Raffaella Gallo, Kathryn Balmanno, et al. 2016. “Identification of DYRK1B as a Substrate of ERK1/2 and Characterisation of the Kinase Activity of DYRK1B Mutants from Cancer and Metabolic Syndrome.” Cellular & Molecular Life Sciences 73 (4): 883–900. doi:10.1007/s00018-015-2032-x.